BEND, OR-Bend Research Inc. is planning a $13 million drug manufacturing facility in northeast Bend as part of its ongoing relationship with pharmaceutical giant Pfizer.

The privately held scientific research and development firm is creating the pharmaceutical research facility from a 12,000-sf warehouse on 2.5 acres on Builders Street. The company purchased the property for $700,000, but will spend another $7 million to expand and renovate the building and $6 million more on equipment and start-up costs, says operations manager Bruce Johnson.

“It sounds like a lot of money, but building out a clean-room type space that pharmaceutical manufacturing requires is expensive,” Johnson tells GlobeSt. “This facility is representative of our close relationship with Pfizer.”

The facility is being built to meet US Food and Drug Administration Good Manufacturing Practices requirements. It will be used exclusively for manufacturing drugs for Pfizer clinical trials, says Johnson. A separate corporation is being created to own and operate the facility, he confirmed.

Employing 92 people, Bend Research is one of Central Oregon’s largest high-tech firms. The company works on several technologies, including synthetic membranes used to clean water and separate gases. It’s main offices, which were recently expanded, are in nearby Tumalo. The new facility will be housed in an existing warehouse at 20503 Builders St., in an area zoned for light industrial. The company also operates a manufacturing facility in a building just south of Bend High School.

Pfizer Inc. is one of the world’s largest pharmaceutical and consumer healthcare companies. Formed in June following the merger of Pfizer and Warner-Lambert, the New York-based conglomerate produces many of the world’s best-known brands including Halls, Tetra, Benadryl, Sudafed, Listerine, Desitin, Schick, Visine, Ben Gay, Lubriderm, Zantac 75 and Cortizone.

Construction on the new facility is expected to begin in January and be completed by November 2001. The company expects to hire between six and 12 additional employees for the new facility next year.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


GlobeSt Net Lease Spring 2024Event

This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.

Get More Information


Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join now!

  • Free unlimited access to's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including and

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.